Anna Dolnik
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Protein Degradation and Inhibitors 7
- Histone Deacetylase Inhibitors Research 4
- Hematology 23
- Acute Myeloid Leukemia Research 17
- Chronic Myeloid Leukemia Treatments 7
- Multiple Myeloma Research and Treatments 5
- Co-authors
- Lars Bullinger (35 shared papers)Hartmut Döhner (20 shared papers)Konstanze Döhner (14 shared papers)Eugen Tausch (3 shared papers)Stephan Stilgenbauer (3 shared papers)Daniel Mertens (3 shared papers)Johannes Bloehdorn (2 shared papers)Tamara J. Blätte (10 shared papers)
- Journals
- Blood (12 papers)Blood Advances (4 papers)Leukemia (3 papers)Molecular Cancer (2 papers)Oncotarget (2 papers)
- Partner nations
- GermanyUnited StatesPoland
In The Last Decade
Anna Dolnik
38 papers receiving 935 citations
Peers
Comparison fields: 5 of 59
- Hematology 327
- Genetics 182
- Cancer Research 213
- Molecular Biology 541
- Pathology and Forensic Medicine 107
Countries citing papers authored by Anna Dolnik
This map shows the geographic impact of Anna Dolnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Dolnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Dolnik more than expected).
Fields of papers citing papers by Anna Dolnik
This network shows the impact of papers produced by Anna Dolnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Dolnik. The network helps show where Anna Dolnik may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Dolnik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 144 | |
| 2 | 2012 | 115 | |
| 3 | 2019 | 85 | |
| 4 | 2018 | 83 | |
| 5 | 2017 | 67 | |
| 6 | 2019 | 56 | |
| 7 | 2006 | 50 | |
| 8 | 2022 | 49 | |
| 9 | 2019 | 45 | |
| 10 | 2022 | 25 | |
| 11 | 2021 | 22 | |
| 12 | 2020 | 20 | |
| 13 | 2020 | 20 | |
| 14 | 2021 | 16 | |
| 15 | 2019 | 16 | |
| 16 | 2014 | 13 | |
| 17 | 2015 | 12 | |
| 18 | 2014 | 11 | |
| 19 | 2003 | 9 | |
| 20 | 2017 | 9 |
About Anna Dolnik
Anna Dolnik is a scholar working on Molecular Biology, Hematology, Genetics, Cancer Research and Oncology, having authored 39 papers that have together received 939 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (17 papers), Protein Degradation and Inhibitors (7 papers), Chronic Myeloid Leukemia Treatments (7 papers), Cancer Genomics and Diagnostics (5 papers), Multiple Myeloma Research and Treatments (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Hematology (327 citations), Genetics (182 citations), Cancer Research (213 citations), Molecular Biology (541 citations) and Pathology and Forensic Medicine (107 citations). Anna Dolnik has collaborated with scholars based in Germany, United States and Poland. Frequent co-authors include Lars Bullinger, Hartmut Döhner, Konstanze Döhner, Eugen Tausch, Stephan Stilgenbauer, Daniel Mertens, Johannes Bloehdorn, Tamara J. Blätte, William Close and Brenda Chyla. Their work appears in journals such as Blood, Blood Advances, Leukemia, Molecular Cancer and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.